Inventor · disambiguated record
Manfred Möwes
Also filed as: MOEWES MANFRED · MÖWES MANFRED
6 granted patents·6 pending applications·3 citations·filing 2011–2016
68Inventor score
Technology areasA61P
Top patents by PatentIndex Score
12 records- 0170US8895549B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Nov 25, 2014·2 cites·15 claims
- 0266US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 0353US9902727B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2014·Granted Feb 27, 2018·0 cites·15 claims
- 0442US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 0542US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 0636US9730943B2Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolinesSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Aug 15, 2017·0 cites·5 claims
- 0736US9675616B2Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolinesSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Jun 13, 2017·0 cites·11 claims
- 0833US2018044306A11,3,4-thiadiazol-2-yl-benzamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 0933US2018042931A1N-phenyl-(morpholin-4-yl or piperazinyl)acetamide derivatives and their use as inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1033US2018028507A13-carbamoylphenyl-4-carboxamide and isophtalamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1131US2017107212A1Novel compoundsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 1231US2017114070A1Inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manfred Möwes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →